Zhou Ling
Research Subjects
Research Interests
Zhou Ling has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Alina D. Oksentyuk
I.M. Sechenov First Moscow State Medical University
2 shared publications - Irina V. Gabbasova
Pyatigorsk Medical and Pharmaceutical Institute, branch of the Volgograd State Medical University of the Ministry of Health of the Russian Federation
2 shared publications - Marina V. Loktionova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
2 shared publications - Tang Hui
Moscow State University of Medicine and Dentistry
2 shared publications - Valeria Alexandrovna Sletova
Pyatigorsk medical and Pharmaceutical Institute – branch of Volgograd State Medical University
2 shared publications - Alexandr Anatolevich Sletov
Ye.A. Vagner Perm State Medical University
1 shared publication
Latest Publications
- Open Access
- 30 March 2024
- Published by Belgorod State University in Актуальные проблемы медицины
- Vol. 47 (1)
Biomechanics of the Patient with Bisphonate Osteonecrosis According to the Diagnosis Neurophysiological Monitoring
Эффективная реабилитация пациентов с объёмными дефектами челюстей на современном этапе развития науки и техники ...
- 30 March 2024
- Published by Belgorod State University in Актуальные проблемы медицины
- Vol. 47 (1)
Open AccessBiomechanics of the Patient with Bisphonate Osteonecrosis According to the Diagnosis Neurophysiological Monitoring
Эффективная реабилитация пациентов с объёмными дефектами челюстей на современном этапе развития науки и техники ...
- Open Access
- 28 March 2023
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 10 (1) , 45-51
Diagnostic analysis of toxic damage due to a dose of zoledronic acid
Introduction: Comprehensive analysis is necessary to analyze the widespread use of bisphosphonate drugs in the treatment and prevention of various diseases of connective tissue structures. The relevance of the study depends on the impact they have on the patient’s somatic condition, given the number of early and late complications diagnosed by domestic and foreign clinicians. Materials and methods: The methodology used was developed on Stavropol Regional Clinical Hospital from 2010 to 2022. A randomized and observational study of the state of connective tissue structures was conducted in 186 patients who had a history of taking zoledronic acid and developed bisphosphonate osteonecrosis of the jawbone. At the diagnostic and treatment stages, patients were tested using laboratory methods to monitor amino acids in biological fluids (blood), as well as bone blocks extracted intraoperatively using highly effective gas-liquid chromatography on AAA 500. Results and discussion: Aminograms obtained in the pre-operative period indicate toxic effects of zoledronic acid on neuro, endocrine, and other human systems. The initiation and progression of aseptic inflammatory processes in tissue structures is correlated with the deteriorating general ocular status of patients when amino acids, such as alanine, serine, taurine, phenylalanine, tyrosine, proline, histidine, glycine, and valine, against a background of 90.4±2.1 mmol/L ammonia are reduced critically. Conclusion: Zoledronic acid initiates an aseptic chronic inflammatory process in the jaw bones, accompanied by toxic acidosis, which worsens osteoporotic symptoms.
- 28 March 2023
- Published by Belgorod National Research University in Research Results in Pharmacology
- Vol. 10 (1) , 45-51
Open AccessDiagnostic analysis of toxic damage due to a dose of zoledronic acid
Introduction: Comprehensive analysis is necessary to analyze the widespread use of bisphosphonate drugs in the treatment and prevention of various diseases of connective tissue structures. The relevance of the study depends on the impact they have on the patient’s somatic condition, given the number of early and late complications diagnosed by domestic and foreign clinicians. Materials and methods: The methodology used was developed on Stavropol Regional Clinical Hospital from 2010 to 2022. A randomized and observational study of the state of connective tissue structures was conducted in 186 patients who had a history of taking zoledronic acid and developed bisphosphonate osteonecrosis of the jawbone. At the diagnostic and treatment stages, patients were tested using laboratory methods to monitor amino acids in biological fluids (blood), as well as bone blocks extracted intraoperatively using highly effective gas-liquid chromatography on AAA 500. Results and discussion: Aminograms obtained in the pre-operative period indicate toxic effects of zoledronic acid on neuro, endocrine, and other human systems. The initiation and progression of aseptic inflammatory processes in tissue structures is correlated with the deteriorating general ocular status of patients when amino acids, such as alanine, serine, taurine, phenylalanine, tyrosine, proline, histidine, glycine, and valine, against a background of 90.4±2.1 mmol/L ammonia are reduced critically. Conclusion: Zoledronic acid initiates an aseptic chronic inflammatory process in the jaw bones, accompanied by toxic acidosis, which worsens osteoporotic symptoms.